Checkmate Pharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Checkmate Pharmaceuticals, Inc.
CIK #0001651431
EDGAR Form CIK 2011 - 2025
10-K [0001651431]
10-Q [0001651431]
3 [0001651431]
4 [0001651431]
8-K [0001651431]
D [0001651431]
SC 13D [0001651431]
SC 13G [0001651431]
Form 13D/13G Filer Form 13D/13G Subject Filed
Gardner Lewis Asset Management L P Checkmate Pharmaceuticals Inc [2022-06-03]
Decheng Capital Management III Cayman LLC Checkmate Pharmaceuticals Inc [2022-02-14]
Omega Fund VI LP Checkmate Pharmaceuticals Inc [2021-02-12]
Clough Capital Partners L P Checkmate Pharmaceuticals Inc [2020-11-10]
venBio Global Strategic Fund II LP Checkmate Pharmaceuticals Inc [2020-10-06]
Longitude Capital Partners III LLC Checkmate Pharmaceuticals Inc [2020-08-21]
Sofinnova Venture Partners IX LP Checkmate Pharmaceuticals Inc [2020-08-19]
Medicxi Growth I LP Checkmate Pharmaceuticals Inc [2020-08-18]
Novo Holdings A/S Checkmate Pharmaceuticals Inc [2020-08-13]
Form 3/4/5 Subject 2011 - 2025
Fuhrman Alan
Checkmate Pharmaceuticals, Inc.
Flaherty Keith T.
Isacoff Oren
Colabuono Peter
Yan Joy
Dolski Robert
Wooldridge James
Wigginton Jon Marc
BASH Alan
View All
Terms | Privacy | Guide
tony@aum13f.com